Jeremy Sherer

Orrick, Herrington & Sutcliffe LLP

+ Follow Contact

Latest Posts › Medical Devices

Share:

FDA Proposes Draft Guidance on Assessing the Credibility of AI Models Used in Drug and Biological Product Submissions

The FDA has shared its first draft guidance on how sponsors should assess the credibility of artificial intelligence (AI) models to support FDA decisions regarding drug safety, effectiveness or quality. The agency noted an...more

1/17/2025 / Artificial Intelligence , Draft Guidance , Food and Drug Administration (FDA) , Life Sciences , Machine Learning , Medical Devices , Pharmaceutical Industry , Risk Management

FDA Issues Draft Guidance on AI-Enabled Medical Devices

The FDA has shared draft guidance on the design and development of AI-enabled medical devices and marketing submissions for those devices. The Importance of Engaging Early Sponsors of AI-enabled devices should engage with the...more

1/8/2025 / Artificial Intelligence , Bias , Cybersecurity , Data Management , Food and Drug Administration (FDA) , Medical Devices , Regulatory Requirements , Risk Management , Software , Transparency

Life Sciences Snapshot – Q4 2024 – A Quarterly Report on Financing Trends

Since the previous quarter’s Life Sciences Snapshot, robust dealmaking activity in Q3 has launched YTD life sciences VC deal activity to near parity with 2023 figures, firmly positioning 2024 as the year to break the two-year...more

12/23/2024 / Biotechnology , Food and Drug Administration (FDA) , Life Sciences , Medical Devices , Pharmaceutical Industry , Prescription Drugs

3 Results

View per page

Page: of 1